Navigation Links
FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Date:2/28/2008

Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to the planned commercial launch of LUVOX CR and Jazz Pharmaceuticals' continuing efforts, including manufacturing to prepare for commercial launch. Words and phrases such as "will," "are proceeding" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Jazz Pharmaceuticals' current expectations. Forward-looking statements involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to when or whether commercial launch of LUVOX CR will occur, Jazz Pharmaceuticals' ability to attain market acceptance of LUVOX CR by physicians, patients and third party payors, Jazz Pharmaceuticals' dependence on single source suppliers and manufacturers, and scaling up manufacturing of LUVOX CR to commercial capacity. These and other risk factors are discussed under "Risk Factors," in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on November 9, 2007. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

(C)2008 Jazz Pharmaceuticals, Inc. SODAS(R) is a registered trademark of Elan Pharma International Limited, Ireland, a subsidiary of Elan Corporation, plc (NYSE; ELN) LUVOX is a registered trademark of Solvay Pharmaceuticals, Inc.

(1) Davidson J, Yaryura-Tobias J, DuPont R, et al. Fluvoxamine-controlled

release formulation for the treatment of
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
2. U.S. Court Approves AK Steels VEBA Health Care Settlement With Middletown Works Retirees
3. Securian Board Approves 8 Officer Promotions
4. MGT Capital Investments, Inc. Approves Share Buyback Program
5. Kaiser Permanente Approves $29 Million in Community Benefit Grants
6. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
7. Pennsylvania Attorney General Approves Vincentian Collaborative System-Marian Manor Integration
8. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
9. FDA Approves Additional Indication for Astellas MYCAMINE(R)
10. FDA Approves Labeling Change for Non-Drowsy CLARITIN(R)
11. FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 Muscular Dystrophy ... Biomedical Engineering at Duke University, recently announced a ... and young men with Duchenne muscular dystrophy (DMD). ... Communications, and Gersbach will discuss their implications at ... 11-14 in Washington, D.C. , Background: Gersbach ...
(Date:2/27/2015)... According to the report, the annual revenue ... in 2013 rose by 31.9%. However, in the first ... generated by the industry was recorded at RMB3.623 billion ... industry in 2013. , View Full Report at ... oral industry as a branch of medical industry that ...
(Date:2/27/2015)... Lake City, UT (PRWEB) February 27, 2015 ... Best and Worst Commuter Cities in Florida " ... traffic data from the 2013 U.S. Census Bureau ... 10,000 at the time of the survey. , ... city level, including methods of commuting and a ...
(Date:2/27/2015)... On time and under budget, the doors ... Inside and out, the nearly 900,000-square-foot facility makes good ... the tornado-ravaged St. John’s Regional Medical Center with a ... just 46 months after the tornado hit Joplin, which ... to plan, design and construct a similarly sized hospital,” ...
(Date:2/27/2015)... Fairfax, VA (PRWEB) February 27, 2015 ... currently accepting applications for its next class of Fellows ... the field of radiology business management. , Since ... the significant contributions made by RBMA members to the ... is a prestigious recognition because each Fellow candidate must ...
Breaking Medicine News(10 mins):Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:RBMA Issues Call for Fellowship Applicants 2
... with rheumatoid arthritis who undergo total knee replacement ... according to a new study by researchers at ... City. These reduced expectations, which may be unnecessary, ... postsurgical rehabilitation leading to worse outcomes, say doctors. ...
... , SATURDAY, Nov. 5 (HealthDay News) -- Exposure to certain ... for the painful joint disease known as rheumatoid arthritis, new ... one of the six most common air pollutants in the ... to be presented Wednesday at the American College of Rheumatology ...
... HealthDay Reporter , FRIDAY, Nov. 4 (HealthDay News) -- A ... identifying a gene that is critical in determining which life-saving ... by Genomic Health, results in a number of false-negatives for ... in the Journal of Clinical Oncology . ...
... Cholesterol-lowering medications may help millions fight heart ... control, according to a study presented at the American ... Boston, Nov. 3-8. In the preliminary study ... medication or statins, to 20 patients with asthma who ...
... lab cultures and mice, Johns Hopkins scientists have found that ... causes colon inflammation and increases activity of a gene ... is to expose the gut to hydrogen peroxide the ... cause DNA damage, contributing to the formation of colon tumors, ...
... role in kidney failure, and blocking the action of this ... according to researchers. "We believe these arginase inhibitors may ... the progression of, or even prevent the development of, end-stage ... Penn State College of Medicine. In the United States diabetes ...
Cached Medicine News:Health News:Rheumatoid arthritis patients have low expectations after knee replacement surgery 2Health News:Rheumatoid arthritis patients have low expectations after knee replacement surgery 3Health News:Studies Suggest Link Between Smog, Joint Disease 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 3Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 2Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 3Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 4Health News:Common bacteria cause some colon tumors by altering peroxide-producing gene 2Health News:Research aims to prevent diabetic kidney failure 2
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015 Legislation ... includes a pharmacy provision to help prevent inappropriate prescriptions ... The Protecting the Integrity of Medicare Act (PIMA) ... Subcommittee Chairman Kevin Brady (R-TX) and Ranking ... the prescription drug abuse epidemic and implement the right ...
(Date:2/26/2015)... , Feb. 26, 2015 Research and Markets ... the "Radiation Therapy Equipment - Global Strategic Business ... This report analyzes the worldwide markets for Radiation Therapy ... Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. ... Canada , Japan ...
(Date:2/26/2015)... 2015  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of virus infections, today announced that Jonathan ... President of Finance, a newly created role.  Mr. ... activities, including financial planning and reporting, accounting and ... Jensen , President and CEO. ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
Scorpio CR Knee is designed to address normal knee kinematics, range of motion (ROM) and polyethylene wear....
... The TC-PLUS Solution tricompartmental total knee ... with knee arthroplasty. State-of-the-art design and manufacturing ... achieve optimum biomechanical function as well as ... polyethylene tibial insert to keep wear to ...
Medicine Products: